Revenue rose 5.9% to over GBP 710 million, with stable 20% EBITDA margin and strong cash conversion. Expansion in Australia is margin accretive, and a GBP 50 million share buyback is underway. The group targets further growth through disciplined acquisitions and digital enhancements.Based on CVS Gr…
Revenue rose 5.9% to over GBP 710 million, with stable 20% EBITDA margin and strong cash conversion. Expansion in Australia is margin accretive, and a GBP 50 million share buyback is underway. The group targets further growth through disciplined acquisitions and digital enhancements.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.